Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: A prospective cohort study on children of women with epilepsy

JAMA Neurology

Volumn 70, Issue 11, 2013, Pages 1367-1374

  Veiby, Gyri ^a,b   Engelsen, Bernt A ^a,b   Gilhus, Nils Erik ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID;

ARTICLE; BREAST FEEDING; CHILD; CHILD DEVELOPMENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL DISORDER; DRUG EXPOSURE; EPILEPSY; FEMALE; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR DISORDER; RISK ASSESSMENT; SOCIAL ADAPTATION;

EID: 84888876222     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.4290     Document Type: Article

References (52)

1. Ikonomidou C, Turski L. Antiepileptic drugs and brain development. Epilepsy Res. 2010;88(1):11-22.
2. Kluger BM, Meador KJ. Teratogenicity of antiepileptic medications. Semin Neurol. 2008;28(3):328-335.
3. Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology. 2011;76(8):719-726.
4. Banach R, Boskovic R, Einarson T, Koren G. Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies. Drug Saf. 2010;33(1):73-79.
5. Forsberg L, Wide K, Källén B. School performance at age 16 in children exposed to antiepileptic drugs in utero: a population-based study. Epilepsia. 2011;52(2):364-369.
6. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597-1605.
7. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology. 2012;78(16):1207-1214.
8. Rydz D, Shevell MI, Majnemer A, Oskoui M. Developmental screening. J Child Neurol. 2005;20(1):4-21.
9. Klein A. Antiepileptic drugs and breastfeeding: do we tell women "no"? Neurology. 2010;75(22):1948-1949.
10. Quigley MA, Hockley C, Carson C, Kelly Y, Renfrew MJ, Sacker A. Breastfeeding is associated with improved child cognitive development: a population-based cohort study. J Pediatr. 2012;160(1):25-32.
11. Renfrew MJ, McCormick FM, Wade A, Quinn B, Dowswell T. Support for healthy breastfeeding mothers with healthy term babies. Cochrane Database Syst Rev. 2012;5:CD001141.
12. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C; MoBa Study Group. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2006;35(5):1146-1150.
13. Roth C, Magnus P, Schjølberg S, et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA. 2011;306(14):1566-1573.
14. Stoltenberg C, Schjølberg S, Bresnahan M, et al; ABC Study Group. The Autism Birth Cohort: a paradigm for gene-environment-timing research. Mol Psychiatry. 2010;15(7):676-680.
15. Veiby G, Daltveit AK, Schjølberg S, et al. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia. 2013;54(8):1462-1472.
16. Robins DL, Fein D, Barton ML, Green JA. The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord. 2001;31(2):131-144.
17. Dumont-Mathieu T, Fein D. Screening for autism in young children: the Modified Checklist for Autism in Toddlers (M-CHAT) and other measures. Ment Retard Dev Disabil Res Rev. 2005;11(3):253-262.
18. Swinkels SH, Dietz C, van Daalen E, Kerkhof IH, van Engeland H, Buitelaar JK. Screening for autistic spectrum in children aged 14 to 15 months, I: the development of the Early Screening of Autistic Traits Questionnaire (ESAT). J Autism Dev Disord. 2006;36(6):723-732.
19. Snow AV, Lecavalier L. Sensitivity and specificity of the Modified Checklist for Autism in Toddlers and the Social Communication Questionnaire in preschoolers suspected of having pervasive developmental disorders. Autism. 2008;12(6):627-644.
20. Dale PS, Price TS, Bishop DV, Plomin R. Outcomes of early language delay, I: predicting persistent and transient language difficulties at 3 and 4 years. J Speech Lang Hear Res. 2003;46(3):544-560.
21. Gollenberg AL, Lynch CD, Jackson LW, McGuinness BM, Msall ME. Concurrent validity of the parent-completed Ages and Stages Questionnaires, 2nd Ed. with the Bayley Scales of Infant Development II in a low-risk sample. Child Care Health Dev. 2010;36(4):485-490.
22. Richter J, Janson H. A validation study of the Norwegian version of the Ages and Stages Questionnaires. Acta Paediatr. 2007;96(5):748-752.
23. Nøvik TS. Validity of the Child Behaviour Checklist in a Norwegian sample. Eur Child Adolesc Psychiatry. 1999;8(4):247-254.
24. Brandlistuen RE, Stene-Larsen K, Holmstrom H, Landolt MA, Eskedal LT, Vollrath ME. Motor and social development in 6-month-old children with congenital heart defects. J Pediatr. 2010;156(2):265-269; e1.
25. Brandlistuen RE, Stene-Larsen K, Holmstrøm H, Landolt MA, Eskedal LT, Vollrath ME. Symptoms of communication and social impairment in toddlers with congenital heart defects. Child Care Health Dev. 2011;37(1):37-43.
26. Schjølberg S, Eadie P, Zachrisson HD, Oyen AS, Prior M. Predicting language development at age 18 months: data from the Norwegian Mother and Child Cohort Study. J Dev Behav Pediatr. 2011;32(5):375-383.
27. Squires J, Bricker D, Potter L. Revision of a parent-completed development screening tool: Ages and Stages Questionnaires. J Pediatr Psychol. 1997;22(3):313-328.
28. Bates JE, Freeland CA, Lounsbury ML. Measurement of infant difficultness. Child Dev. 1979;50(3):794-803.
29. Achenbach TM, Edelbrock C, Howell CT. Empirically based assessment of the behavioral/emotional problems of 2- and 3- year-old children. J Abnorm Child Psychol. 1987;15(4):629-650.
30. Rutter M. Autism: its recognition, early diagnosis, and service implications. J Dev Behav Pediatr. 2006;27(2)(suppl):S54-S58.
31. Strand BH, Dalgard OS, Tambs K, Rognerud M. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003;57(2):113-118.
32. Croy CD, Novins DK. Methods for addressing missing data in psychiatric and developmental research. J Am Acad Child Adolesc Psychiatry. 2005;44(12):1230-1240.
33. D'Agostino RB Jr. Propensity scoremethods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281.
34. Bromley RL, Mawer G, Love J, et al; Liverpool and Manchester Neurodevelopment Group (LMNDG). Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia. 2010;51(10):2058-2065.
35. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Foetal antiepileptic drug exposure and verbal vs non-verbal abilities at three years of age. Brain. 2011;134(pt 2):396-404.
36. Harden CL, Pennell PB, Koppel BS, et al; American Academy of Neurology; American Epilepsy Society. Management issues for women with epilepsy: focus on pregnancy (an evidence-based review), III: vitamin K, folic acid, blood levels, and breast-feeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50(5):1247-1255.
37. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010;75(22):1954-1960.
38. Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav. 2004;5(1):102-105.
39. Sabers A, Tomson T. Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol. 2009;22(2):157-161.
40. Tomson T, Battino D, Bonizzoni E, et al; EURAP Study Group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10(7):609-617.
41. Newport DJ, Pennell PB, Calamaras MR, et al. Lamotrigine in breastmilk and nursing infants: determination of exposure. Pediatrics. 2008;122(1):e223- e231.
42. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia. 2000;41(6):709-713.
43. Rauchenzauner M, Kiechl-Kohlendorfer U, Rostasy K, Luef G. Old and new antiepileptic drugs during pregnancy and lactation: report of a case. Epilepsy Behav. 2011;20(4):719-720.
44. Nordmo E, Aronsen L, Wasland K, Småbrekke L, Vorren S. Severe apnea in an infant exposed to lamotrigine in breastmilk. Ann Pharmacother. 2009;43(11):1893-1897.
45. Schultz ST, Klonoff-Cohen HS, Wingard DL, et al. Breastfeeding, infant formula supplementation, and autistic disorder: the results of a parent survey. Int Breastfeed J. 2006;1:16.
46. Tanoue Y, Oda S. Weaning time of children with infantile autism. J Autism Dev Disord. 1989;19(3):425-434.
47. Möricke E, Swinkels SH, Beuker KT, Buitelaar JK. Predictive value of subclinical autistic traits at age 14-15 months for behavioural and cognitive problems at age 3-5 years. Eur Child Adolesc Psychiatry. 2010;19(8):659-668.
48. Nohr EA, Frydenberg M, Henriksen TB, Olsen J. Does low participation in cohort studies induce bias? Epidemiology. 2006;17(4):413-418.
49. Nilsen RM, Vollset SE, Gjessing HK, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009;23(6):597-608.
50. Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 2009;50(9):2130-2139.
51. Sachse S, Von Suchodoletz W. Early identification of language delay by direct language assessment or parent report? J Dev Behav Pediatr. 2008;29(1):34-41.
52. Kristiansen AL, Lande B, Øverby NC, Andersen LF. Factors associated with exclusive breast-feeding and breast-feeding in Norway. Public Health Nutr. 2010;13(12):2087-2096.